No Data
No Data
As Medtronic (NYSE:MDT) Increases 4.2% This Past Week, Investors May Now Be Noticing the Company's Three-year Earnings Growth
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $104
Medtronic (MDT) Gets a Buy From Barclays
Medtronic Stock: Here's What to Expect From Q1 Earnings
Tesla, Palo Alto Networks, Estee Lauder, FuboTV, and More Stock Market Movers
The Trader: Medtronic Stock Has Hit Been by Anti-Obesity Concerns. Why It Should Rebound. -- Barron's